| Size | Price | Stock |
|---|---|---|
| 10mg | $35 | In-stock |
| 25mg | $80 | In-stock |
| 50mg | $120 | In-stock |
| 100mg | $180 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-B1547A |
| M.Wt: | 398.93 |
| Formula: | C23H27ClN2O2 |
| Purity: | >98 % |
| Solubility: | DMSO : ≥ 32 mg/mL;H2O : 16.67 mg/mL (ultrasonic) |
Benzetimide hydrochloride (R4929) is a blood-brain barrier-permeable muscarinic acetylcholine receptor antagonist. Benzetimide hydrochloride blocks cholinergic receptor sites. Benzetimide hydrochloride induces mydriasis, prevents acetylcholine-induced muscle contraction, inhibits pilocarpine (HY-B0726A)-induced parasympathomimetic effects, and exhibits antisecretory activity. Benzetimide hydrochloride can be used in research related to Parkinson's disease[1][2].
In Vitro:Benzetimide ((+) Benzetimide) (0.02 mg/L; 30-60 min) hydrochloride inhibits acetylcholine-induced contraction of guinea pig ileal segments, whereas (-) Benzetimide at the same concentration achieves higher tissue radioactivity levels but exhibits no inhibitory activity[1].
In Vivo:Benzetimide hydrochloride (0.04-4 mg/kg; s.c.; single dose) has anticholinergic activity exclusively due to its (+) enantiomer, which induces marked mydriasis in rats at a dose of 0.04 mg/kg, while the (-) enantiomer shows no mydriatic effect at 4 mg/kg[1].
Benzetimide hydrochloride (0.5 mg/kg; s.c.; single dose) has both (+) and (-) isomers that are predominantly excreted within 24 hours of subcutaneous administration, with the (-) enantiomer excreted more rapidly via urine and the (+) enantiomer excreted more heavily via feces, and with distinct metabolite proportion profiles between the isomers[1].
Benzetimide hydrochloride (2.5 mg/kg; s.c.; single dose) has both (+) and (-) isomers that penetrate rat eye and brain tissue, but only the (+) enantiomer produces anticholinergic effects (mydriasis), which are not correlated with general tissue radioactivity levels[1].
Benzetimide hydrochloride (0.02-10 mg/kg; s.c.) is a powerful antagonist of both peripheral and central parasympathomimetic effects of Pilocarpine (HY-B0726A), with an ED50AS of 0.04 mg/kg, ED50MY of 0.06 mg/kg, and ED50CA of 0.08 mg/kg[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.